MoneyWorks4Me

Alembic Pharmaceuticals informs about clarification

26 May 2021 Evaluate
Alembic Pharmaceuticals has informed that the exchange has sought clarification from Alembic Pharmaceuticals with respect to news article appearing on www.financialexpress.com May 25, 2021 titled ‘Alembic gets Gujarat FDCA licence for anti-black fungal drug Amphotericin-B’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..